Sarika Singh Ph.D.
Attorney - Intellectual PropertyDr. Singh's is an intellectual property attorney with extensive experience in patent procurement, litigation, and counseling in the field of pharmaceuticals, chemicals, nutraceuticals, polymers, biochemistry and biotechnology. She has significant experience in advising clients on Hatch-Waxman patent and regulatory law, and provides patent infringement, validity, freedom to operate and clearance opinion relating to ANDA (Abbreviated New Drug Application) preparation and submissions. I have represented clients on both generic and branded sides in Hatch-Waxman litigation. She has prepared and prosecuted patent applications covering a wide variety of technology including therapeutic small molecules, biologics, medical and diagnostic devices, processed food, and polymers relating to inks, artificial leather, and optical devices.
- Intellectual Property
- Patents
- Patent Appeals, Patent Litigation, Patent Prosecution
- New Jersey
- New York
- Hindi: Spoken, Written
- Punjabi: Spoken
- Counsel
- McNeely Hare & War LLP
- - Current
- Associate
- McDermott, Will & Emery
- -
- Attorney, Law Clerk
- McNeely & Hare LLP
- -
- Director- Global IP
- Ranbaxy Inc., USA
- -
- Senior Patent Scientist
- Ranbaxy Europe Ltd.
- -
- Group Leader/ Research Scientist - IP
- Ranbaxy Laboratories Ltd.
- -
- Rutgers School of Law-Newark
- J.D. | Law
- -
- University of Delhi
- Ph.D. | Synthetic Organic Chemistry
- -
- American Chemical Society
- member
- Current
- Deoxygenation of Sulfoxides and Selenoxides with Nickel Boride
- Tetrahedron Lett. 1998, 3829
- Oxidative hydrolysis of Hydrazones, Semicarbazones and Phenylhydrazones with Sodium hypochlorite
- J. Chem. Res. (S) 1996, 532
- Reductive coupling of Nitroarenes to Hydrazoarenes with Al-KOH in methanol
- J. Chem. Soc., Perkin Trans. 1., 1999, 1893.
- Pro se not welcome at PTAB
- Lexology
- Generic Drugs – Hatch-Waxman Act as amended by the Medicare Modernization Act, Global IP Convention, New Delhi